Cargando…
Feasibility and suitability of a graded exercise test in patients with aggressive hemato-oncological disease
PURPOSE: Physical activity promises to reduce disease-related symptoms and therapy-related side effects in patients suffering from aggressive lymphoma (L) or acute leukemia (AL). For an efficient training program, determination of patients’ physical capacity with a purposive exercise test is crucial...
Autores principales: | Großek, Anja, Elter, Thomas, Oberste, Max, Wolf, Florian, Joisten, Niklas, Hartig, Philipp, Walzik, David, Rosenberger, Friederike, Kiesl, David, Wahl, Patrick, Bloch, Wilhelm, Zimmer, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236443/ https://www.ncbi.nlm.nih.gov/pubmed/33544247 http://dx.doi.org/10.1007/s00520-021-06035-w |
Ejemplares similares
-
Effects and Moderators of Acute Aerobic Exercise on Subsequent Interference Control: A Systematic Review and Meta-Analysis
por: Oberste, Max, et al.
Publicado: (2019) -
Physical Exercise as Kynurenine Pathway Modulator in Chronic Diseases: Implications for Immune and Energy Homeostasis
por: Joisten, Niklas, et al.
Publicado: (2020) -
Acute exercise impacts AhR and PD-1 levels of CD8(+) T-cells—Exploratory results from a randomized cross-over trial comparing endurance versus resistance exercise
por: Schenk, Alexander, et al.
Publicado: (2020) -
Protocol for the “Chemobrain in Motion – study” (CIM – study): a randomized placebo-controlled trial of the impact of a high-intensity interval endurance training on cancer related cognitive impairments in women with breast cancer receiving first-line chemotherapy
por: Oberste, Max, et al.
Publicado: (2018) -
Transferring clinically established immune inflammation markers into exercise physiology: focus on neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index
por: Walzik, David, et al.
Publicado: (2021)